Organogenesis Holdings Inc (ORGO)
NASDAQ:ORGO
Holding ORGO?
Track your performance easily

Organogenesis Holdings (ORGO) Financial Statements

397 Followers

Organogenesis Holdings Financial Overview

Organogenesis Holdings's market cap is currently ―. The company's EPS TTM is $-0.125; its P/E ratio is -26.22; Organogenesis Holdings is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 130.23M$ 109.98M$ 99.65M$ 108.53M$ 117.32M
Gross Profit$ 101.04M$ 81.28M$ 71.88M$ 82.74M$ 91.00M
EBIT$ -13.92M$ -3.83M$ -1.29M$ 8.08M$ 9.77M
EBITDA$ -7.56M$ 2.35M$ 11.00M$ 11.86M$ 15.18M
Net Income Common Stockholders$ -17.04M$ -2.10M$ -569.00K$ 3.17M$ 5.32M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 89.90M$ 88.63M$ 103.84M$ 98.23M$ 88.92M
Total Assets$ 443.16M$ 458.48M$ 460.02M$ 462.65M$ 450.31M
Total Debt$ 93.49M$ 96.63M$ 98.98M$ 122.81M$ 122.67M
Net Debt$ 3.59M$ 8.00M$ -4.86M$ 24.59M$ 33.75M
Total Liabilities$ 179.66M$ 180.45M$ 181.36M$ 185.78M$ 179.03M
Stockholders Equity$ 263.50M$ 278.03M$ 278.66M$ 276.87M$ 271.28M
Cash Flow-
Free Cash Flow$ 2.86M$ -12.38M$ 7.29M$ 10.76M$ 1.15M
Operating Cash Flow$ 4.74M$ -10.16M$ 10.61M$ 16.73M$ 8.65M
Investing Cash Flow$ -1.88M$ -2.22M$ -3.32M$ -5.98M$ -7.50M
Financing Cash Flow$ -1.73M$ -2.61M$ -1.78M$ -1.44M$ -1.05M
Currency in USD

Organogenesis Holdings Earnings and Revenue History

Organogenesis Holdings Debt to Assets

Organogenesis Holdings Cash Flow

Organogenesis Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis